ArticleAlzheimer's research & therapy2025

Comparative dementia risk with GLP1 receptor agonists, SGLT2 inhibitors, or DPP4 inhibitors: a population-based cohort study.

Che-Yuan Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.